Jon R. Levine - 07 May 2025 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jon R. Levine
Issuer symbol
MRMD
Transactions as of
07 May 2025
Net transactions value
-$2,625
Form type
4
Filing time
09 May 2025, 16:05:52 UTC
Previous filing
29 Apr 2025
Next filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Levine Jon R President and CEO, Director, 10%+ Owner C/O MARIMED INC., 10 OCEANA WAY, NORWOOD, /s/ Jon R. Levine 09 May 2025 0001789645

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +75,000 +0.36% $0.000000 20,734,529 07 May 2025 Direct F1
transaction MRMD Common stock Tax liability $2,625 -25,988 -0.13% $0.1010 20,708,541 07 May 2025 Direct F2
holding MRMD Common stock 6,684,640 07 May 2025 By the Jon Levine Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -75,000 -25% $0.000000 225,000 07 May 2025 Common Stock, par value $.001 per share 75,000 Direct F1, F4
transaction MRMD Restricted Stock Units (RSU) Award $0 +269,578 $0.000000 269,578 09 May 2025 Common Stock, par value $.001 per share 269,578 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of the RSUs.
F3 These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 The RSUs were granted on November 7, 2023; the remaining unvested RSUs will vest in three equal installments on each of November 7, 2025, May 7, 2026 and November 7, 2026 in accordance with the terms of an agreement between the Issuer and the Reporting Person.
F5 The RSUs will vest in three equal installments on June 15, 2025, September 15, 2025 and December 15, 2025 in accordance with an agreement between the Issuer and the Reporting Person.